No CrossRef data available.
Article contents
521 – Serotoninergic Antidepressants and Anticoagulants in Psychogeriatric Wards, Mental Hospital Kromeriz, Czech Republic - What shall we do to Prevent from Serious Drug Interactions?
Published online by Cambridge University Press: 15 April 2020
Abstract
Both serotoninergic antidepressants and anticoagulants are widely udes in psychogeriatry. These drugs can develop drug interactions with subsequent risk of bleeding.
To determine risk of potential drug interactions between serotoninergic antidepressants and anticoagulants serotoninergic antidepressants and anticoagulants with subsequent risk of bleeding.
Retrospective analysis of medical records and laboratory checks (INR values) in senior patients treated with serotoninergic antidepressants and anticoagulants (Mental hospital Kromeriz, Czech republic, year 2011).
In 15.5% of patients treated with combination serotoninergic antidepressant / anticoagulant the dosage of anticoagulant had to be decreased due to unwanted elevation of INR value. In 0.6% of patients the risk of bleeding was clinically evident.
Serotoninergic antidepressants and anticoagulants are common drugs used in treating seniors with mental disorder and potential drug interactions between them should be taken into account.
- Type
- Abstract
- Information
- European Psychiatry , Volume 28 , Issue S1: Abstracts of the 21th European Congress of Psychiatry , 2013 , 28-E112
- Copyright
- Copyright © European Psychiatric Association 2013
Comments
No Comments have been published for this article.